Researchers connected EHR systems from Rochester, Minn.-based Mayo Clinic and Vanderbilt University Medical Center in Nashville, Tenn., to compile a cohort of 111,673 adult cancer patients. Researchers then identified a sub-cohort of patients with type 2 diabetes and analyzed the effect a diabetes drug, metformin, had on all-cause mortality.
After controlling for age, diagnosis, comorbidities and other factors, results showed a 22 percent reduction in mortality among patients taking metformin at a 95 percent confidence level. Researchers conclude using EHR data is an efficient and inexpensive way of determining if a drug might have a second purpose.
More Articles on EHRs:
Hospitals Respond to CMS’ Proposed MU Flexibility, Ask for Changes
UNC Health Care Rebounds Financially After Epic Implementation
7 Clinical Integration Success Factors for Short-Term Wins
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
